Latest Articles

Publication Date
AIM ImmunoTech announces four presentations on Ampligen at MSCI MSCS-2025 - TipRanks

AIM ImmunoTech announces four presentations on Ampligen at MSCI MSCS-2025 TipRanks

Published: Aug. 6, 2025, 5:42 p.m.
Mother with stage four endometriosis launches petition to raise awareness of ‘painful’ condition in schools - Northampton Chronicle and Echo

Mother with stage four endometriosis launches petition to raise awareness of ‘painful’ condition in schools Northampton Chronicle and Echo

Published: Aug. 6, 2025, 1:37 p.m.
Shell Q2 Earnings Beat Even as Production & Oil Prices Fall - The Globe and Mail

Shell Q2 Earnings Beat Even as Production & Oil Prices Fall The Globe and Mail

Published: Aug. 6, 2025, 1:12 p.m.
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail

Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences The Globe and Mail

Published: Aug. 6, 2025, 1:11 p.m.
AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in - GlobeNewswire

AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in GlobeNewswire

Published: Aug. 6, 2025, 1:03 p.m.
CSX Executive Vice President and Chief Commercial Officer to Address Deutsche Bank’s 2025 Transportation Conference - The Globe and Mail

CSX Executive Vice President and Chief Commercial Officer to Address Deutsche Bank’s 2025 Transportation Conference The Globe and Mail

Published: Aug. 6, 2025, 1 p.m.
7 Dividend Stocks for 2025 — Some Pay Over 8%, Some Just Refuse to Die - The Globe and Mail

7 Dividend Stocks for 2025 — Some Pay Over 8%, Some Just Refuse to Die The Globe and Mail

Published: Aug. 6, 2025, 12:57 p.m.
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY

Published: Aug. 6, 2025, 9:30 a.m.
Kate's chosen path to single parenting, led by love, strength and determination - The Border Mail

Kate's chosen path to single parenting, led by love, strength and determination The Border Mail

Published: Aug. 6, 2025, 9:01 a.m.
Mumbai: Worrying rise in non-respiratory TB, say doctors - Mid-day

Mumbai: Worrying rise in non-respiratory TB, say doctors Mid-day

Published: Aug. 6, 2025, 1:49 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!